Eli Lilly is a global pharmaceutical company with core franchises in diabetes, obesity, oncology, immunology, neuroscience and rare diseases. Market attention is centered on its GLP-1/GIP metabolic-drug portfolio, while pipeline progress, manufacturing capacity expansion and pricing/reimbursement policy remain key long-term variables.
Advertisement
Advertisement
RLLY
Rank #6924Eli Lilly and Co rStock
1,410.76
Nov 09, 22:44 UTC
Eli Lilly and Co rStock (RLLY) Profile
About
Info & Links
Website
Contracts
- arbitrum-one:0x3d1…782d5
- morph-l2:0xd4f…bad07
Read More
RLLY Statistics
24H Low/High
$1,351.67$1,418.09
- Rank#6,924
- Market Cap$66,508
- Fully Diluted Valuation$69,850
- Circulating Supply47
- Max Supply-
- Total Supply50
- 24H Trading Vol$48,544
- Hashing Algorithm-
- Block Mining Time-
Performance Table
Change vs. USD
1D
N/A
7D
+0.18%
30D
+20.11%
6M
N/A
YTD
N/A
1Y
N/A
Circulating/Total
95.08%
Mkt Dominance
0.00%
RLLY Social Stats
- Twitter Followers-
- Reddit Subscribers-
- Reddit Average Active Accounts-
- Reddit Average New Posts Per Hour-
- Reddit Average Comments Per Hour-
- Telegram Channel Users-